Human Genome Epidemiology Literature Finder
Records 1 - 23 (of 23 Records) |
Query Trace: Lung Neoplasms and FAS[original query] |
---|
Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2. Journal of cancer research and clinical oncology 2002 Nov 128 (11): 581-8. Yoshimura Chie, Nomura Shosaku, Kanazawa Shigenori, Kuwana Midori, Muramatsu Mikiko, Yamaguchi Kazuyuki, Fukuhara Shir |
Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer. Lung cancer (Amsterdam, Netherlands) 2003 Oct 42 (1): 1-8. Wang Li-E, Cheng Lie, Spitz Margaret R, Wei Qing |
FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. The Journal of experimental medicine 2005 Oct 202 (7): 967-74. Sun Tong, Zhou Yifeng, Li Hua, Han Xiaohong, Shi Yuankai, Wang Li, Miao Xiaoping, Tan Wen, Zhao Dan, Zhang Xuemei, Guo Yongli, Lin Dongx |
Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer. Journal of medical genetics 2005 Jun 42 (6): 479-84. Zhang X, Miao X, Sun T, Tan W, Qu S, Xiong P, Zhou Y, Lin |
Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population. Lung cancer (Amsterdam, Netherlands) 2006 Dec 54 (3): 303-8. Park Sun Ha, Choi Jin Eun, Kim Eun Jin, Jang Jin Sung, Lee Won Kee, Cha Sung Ick, Kim Chang Ho, Kam Sin, Kim Dong Sun, Park Rang-Woon, Kim Young-Chul, Han Sung Beom, Jung Tae Hoon, Park Jae Yo |
Fas-1377 A/G polymorphism in lung cancer. In vivo (Athens, Greece) 0 21 (4): 663-6. Gormus Uzay, Ergen Arzu, Yaylim-Eraltan Ilhan, Yilmaz Hulya, Turna Akif, Bozkurt Nilüfer, Isbir Turg |
Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer. Carcinogenesis 2008 Nov 29 (11): 2147-52. Ter-Minassian Monica, Zhai Rihong, Asomaning Kofi, Su Li, Zhou Wei, Liu Geoffrey, Heist Rebecca Suk, Lynch Thomas J, Wain John C, Lin Xihong, De Vivo Immaculata, Christiani David |
Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Mar 15 (5): 1794-800. Park Jae Yong, Lee Won-Kee, Jung Duk-Ku, Choi Jin-Eun, Park Tae-In, Lee Eung-Bae, Cho Sukki, Park Ji-Young, Cha Sung-Ick, Kim Chang-Ho, Kam Sin, Jung Tae Hoon, Jheon Sangho |
International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants. Carcinogenesis 2010 Apr 31 (4): 625-33. Truong Therese, Sauter Wiebke, McKay James D, Hosgood H Dean, Gallagher Carla, Amos Christopher I, Spitz Margaret, Muscat Joshua, Lazarus Philip, Illig Thomas, Wichmann H Erich, Bickeböller Heike, Risch Angela, Dienemann Hendrik, Zhang Zuo-Feng, Naeim Behnaz Pezeshki, Yang Ping, Zienolddiny Shanbeh, Haugen Aage, Le Marchand Loïc, Hong Yun-Chul, Kim Jin Hee, Duell Eric J, Andrew Angeline S, Kiyohara Chikako, Shen Hongbing, Matsuo Keitaro, Suzuki Takeshi, Seow Adeline, Ng Daniel P K, Lan Qing, Zaridze David, Szeszenia-Dabrowska Neonilia, Lissowska Jolanta, Rudnai Peter, Fabianova Eleonora, Constantinescu Vali, Bencko Vladimir, Foretova Lenka, Janout Vladimir, Caporaso Neil E, Albanes Demetrius, Thun Michael, Landi Maria Teresa, Trubicka Joanna, Lener Marcin, Lubinski Jan, , Wang Ying, Chabrier Amélie, Boffetta Paolo, Brennan Paul, Hung Rayjean |
A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Sep 17 (18): 5991-9. Sung Wen-Wei, Wang Yao-Chen, Cheng Ya-Wen, Lee Ming-Ching, Yeh Kun-Tu, Wang Lee, Wang John, Chen Chih-Yi, Lee Hu |
Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer. Molecular carcinogenesis 2013 Dec 52 (12): 923-31. Liu Li, Wu Jing, Zhong Rong, Wu Chen, Zou Li, Yang Beifang, Chen Wei, Zhu Beibei, Duan Shengyu, Yu Dianke, Tan Wen, Nie Shaofa, Lin Dongxin, Miao Xiaopi |
Genome-wide gene-environment interaction analysis for asbestos exposure in lung cancer susceptibility.
Carcinogenesis 2012 Aug 33 (8): 1531-7. Wei Sheng, Wang Li-E, McHugh Michelle K, Han Younghun, Xiong Momiao, Amos Christopher I, Spitz Margaret R, Wei Qingyi W |
Prognostic assessment of apoptotic gene polymorphisms in non-small cell lung cancer in Chinese. Journal of biomedical research 2013 May 27 (3): 231-8. Cao Songyu, Wang Cheng, Huang Xinen, Dai Juncheng, Hu Lingmin, Liu Yao, Chen Jiaping, Ma Hongxia, Jin Guangfu, Hu Zhibin, Xu Lin, Shen Hongbi |
MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patients. Cancer research 2013 Feb . Pu X, Roth JA, Hildebrandt MA, Ye Y, Wei H, Minna JD, Lippman SM, Wu X |
Association of Fas -1377 G/A polymorphism with susceptibility to cancer. PloS one 2014 9 (2): e88748. Geng Peiliang, Li Jianjun, Ou Juanjuan, Xie Ganfeng, Wang Ning, Xiang Lisha, Sa Rina, Liu Chen, Li Hongtao, Liang Houj |
Prognostic role of apoptosis-related gene functional variants in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy. OncoTargets and therapy 2015 8 147-55. Tao Kai-Yi, Li Xian-Xing, Xu Wei-Zhen, Wang Yin, Zhu Shuang-Mei, Xie Hua-Xia, Luo Wen-Hua, Xu Yan-Jun, Xu Xiao-Li |
Associations between FAS rs2234767 and FASL rs763110 polymorphisms and the risk of lung cancer: a meta-analysis of 39,736 subjects. OncoTargets and therapy 2016 9 2049-56. Yu Xiongjie, Li Yanli, Yu Yuandong, Lei Jinhua, Wan Guoxing, Cao Fengj |
FAS and FASL genetic polymorphisms impact on clinical outcome of malignant pleural mesothelioma. OncoTargets and therapy 2016 9 6857-6863. El-Hamamsy Manal, Ghali Ramy R, Saad Amr S, Shaheen Sara M, Salem Ahmed |
Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus. Molecular carcinogenesis 2017 Feb . Yin Jieyun, Liu Hongliang, Liu Zhensheng, Owzar Kouros, Han Younghun, Su Li, Wei Yongyue, Hung Rayjean J, Brhane Yonathan, McLaughlin John, Brennan Paul, Bickeboeller Heike, Rosenberger Albert, Houlston Richard S, Caporaso Neil, Landi Maria Teresa, Heinrich Joachim, Risch Angela, Christiani David C, Amos Christopher I, Wei Qing |
Targeted next-generation sequencing reveals recurrence-associated genomic alterations in early-stage non-small cell lung cancer. Oncotarget 2018 Nov 9 (91): 36344-36357. Cho William C S, Tan Kien Thiam, Ma Victor W S, Li Jacky Y C, Ngan Roger K C, Cheuk Wah, Yip Timothy T C, Yang Yi-Ting, Chen Shu-J |
Contribution of programmed cell death 6 genetic variations, gender, and smoking status to lung cancer. OncoTargets and therapy 2019 12 6237-6244. Shen Te-Chun, Chang Wen-Shin, Hsia Te-Chun, Li Hsin-Ting, Chen Wei-Chun, Tsai Chia-Wen, Bau Da-Ti |
Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 May . Datar Ila, Sanmamed Miguel F, Wang Jun, Henick Brian S, Choi Jungmin, Badri Ti, Dong Weilai, Mani Nikita, Toki Maria, Mejías Luis D, Lozano Maria D, Perez-Gracia Jose Luis, Velcheti Vamsidhar, Hellmann Matthew D, Gainor Justin F, McEachern Kristen, Jenkins David, Syrigos Konstantinos, Politi Katerina, Gettinger Scott, Rimm David L, Herbst Roy S, Melero Ignacio, Chen Lieping, Schalper Kurt |
High Expression of Fas-Associated Factor 1 Indicates a Poor Prognosis in Non-Small-Cell Lung Cancer. Current oncology (Toronto, Ont.) 2023 11 30 (11): 9484-9500. De Hu, Hidetaka Yamada, Katsuhiro Yoshimura, Tsutomu Ohta, Kazuo Tsuchiya, Yusuke Inoue, Kazuhito Funai, Takafumi Suda, Yuji Iwashita, Takuya Watanabe, Hiroshi Ogawa, Nobuhito Kurono, Kazuya Shinmura, Haruhiko Sugimu |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: